Skip to content

Roivant Sciences ROIV Ratios & Valuation

TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25TTM Q4 '24
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio123.3×-15.1×138.4×-7.2×145.6×+23.3×122.3×+12.6×109.7×+8.2×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×-0.1×
Per Share
Book value per share$25.45+0.2%$25.38-4.0%$26.44-2.2%$27.04-2.1%$27.60-2.5%
Valuation
Market capitalization$53.09B+31.2%$40.47B+19.1%$33.99B+5.7%$32.15B+0.2%$32.08B-3.8%
Price / sales4,379.9×+2,152×2,227.6×+852×1,376×+279×1,097×+123×974.1×+78.1×
Price / book12.1×+2.8×9.2×+1.9×7.4×+0.7×6.6×+0.4×6.3×+0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Roivant Sciences's ratios come from?
Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.